Cellumed Co. Ltd
Cellumed Co.,Ltd., a biotechnology company, provides bone graft materials, medical devices, and cosmeceuticals in South Korea. The company offers CLnZyme, a mRNA enzyme; cosmeceuticals, such as FGF7 for skin regeneration and TGFß-1 for tissue regeneration; and electric motorcycles. It provides tissue bank products, such as celluderm powder, ultra, and HD implant for the skin; patellar tendon hemi… Read more
Cellumed Co. Ltd (049180) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.018x
Based on the latest financial reports, Cellumed Co. Ltd (049180) has a cash flow conversion efficiency ratio of -0.018x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-294.63 Million) by net assets (₩16.52 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cellumed Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Cellumed Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Cellumed Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cellumed Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ALLERGY THER. PLC LS-001
F:HHU
|
N/A |
|
Ouro Fino Saúde Animal Participações S.A
SA:OFSA3
|
0.046x |
|
Mutual-Tek Industries Co., Ltd.
TWO:6407
|
0.116x |
|
Shangri La Hotels Malaysia Bhd
KLSE:5517
|
0.055x |
|
Romerike Sparebank
OL:ROMER
|
-0.198x |
|
Careium AB
ST:CARE
|
0.102x |
|
District Metals Corp.
PINK:DMXCF
|
-0.032x |
|
Marathon Bancorp, Inc. Common Stock
PINK:MBBC
|
0.030x |
Annual Cash Flow Conversion Efficiency for Cellumed Co. Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Cellumed Co. Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩8.78 Billion | ₩-418.53 Million | -0.048x | +79.65% |
| 2023-12-31 | ₩23.02 Billion | ₩-5.40 Billion | -0.234x | -48.97% |
| 2022-12-31 | ₩53.94 Billion | ₩-8.49 Billion | -0.157x | +30.01% |
| 2021-12-31 | ₩47.99 Billion | ₩-10.79 Billion | -0.225x | -108.37% |
| 2020-12-31 | ₩28.10 Billion | ₩-3.03 Billion | -0.108x | -218.21% |
| 2019-12-31 | ₩5.18 Billion | ₩472.90 Million | 0.091x | +217.96% |
| 2018-12-31 | ₩23.02 Billion | ₩-1.78 Billion | -0.077x | +43.15% |
| 2017-12-31 | ₩37.28 Billion | ₩-5.07 Billion | -0.136x | -48.08% |
| 2016-12-31 | ₩46.56 Billion | ₩-4.28 Billion | -0.092x | +17.86% |
| 2015-12-31 | ₩41.27 Billion | ₩-4.62 Billion | -0.112x | +15.92% |
| 2014-12-31 | ₩44.01 Billion | ₩-5.86 Billion | -0.133x | -1907.43% |
| 2013-12-31 | ₩49.20 Billion | ₩362.28 Million | 0.007x | -15.57% |
| 2012-12-31 | ₩48.75 Billion | ₩425.13 Million | 0.009x | -69.52% |
| 2011-12-31 | ₩31.75 Billion | ₩908.37 Million | 0.029x | -- |